F-Prime Capital Partners vs Foresite Capital
Two firms that co-invest: side by side on stage, sector, check size, and track record, from public filings and the firms' own sites.
| F-Prime Capital Partners | Foresite Capital | |
|---|---|---|
| Type | Venture capital | Venture capital |
| HQ | Cambridge | Larkspur |
| Founded | 2002 | 2011 |
| Check size | $3M – $10M | — |
| Stages | Pre-Seed, Seed, Series A, Series B, Series C, Growth, Late Stage | Pre-Seed, Seed, Series A, Series B, Series C, Growth, Late Stage |
| Sectors | Biotech, Crypto & Web3, Deep Tech, Digital Health, Enterprise Software, Fintech, Healthtech, Medical Devices, SaaS | AI & Machine Learning, Biotech, Digital Health, Healthtech, Longevity, Medical Devices |
| AUM | $13B | $3.2B |
| Tracked investments | 378 | 186 |
| Exits (acquired/public) | 6 | 1 |
| Dated deals, last 24 mo | 5 | 4 |
Shared portfolio · 11
Aclaris TherapeuticsBeam TherapeuticsBlueprint MedicinesCompass TherapeuticsDenali TherapeuticsEngrail TherapeuticsInsmedOrchard TherapeuticsXaira TherapeuticsBicara TherapeuticsStructure Therapeutics
Frequently asked questions
- Do F-Prime Capital Partners and Foresite Capital invest together?
- Yes — F-Prime Capital Partners and Foresite Capital appear together in 11 tracked portfolio companies, including Aclaris Therapeutics, Beam Therapeutics, Blueprint Medicines, Compass Therapeutics, Denali Therapeutics.